Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 7, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Verve Therapeutics, Inc. (NASDAQ: VERV) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term VERV stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or...
2025-01-07 5:37 PM EST
Kuehn Law Encourages Investors of ON24, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 7, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ON24, Inc. (NYSE: ONTF) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term ONTF stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833)...
2025-01-07 5:34 PM EST
Kuehn Law Encourages Investors of Methode Electronics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 6, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Methode Electronics, Inc. (NYSE: MEI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Methode insiders caused the company to misrepresent or fail to disclose that (i) Methode Electronics lost skilled employees during the COVID-19 pandemic, hindering their transition to a high mix, low...
2025-01-06 10:04 PM EST
Kuehn Law Encourages Investors of Orthofix Medical Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 6, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Orthofix Medical Inc. (NASDAQ: OFIX) breached their fiduciary duties to shareholders. A federal securities lawsuit alleges that Orthofix Medical insiders caused the company to misrepresent or fail to disclose material information regarding the conduct of the management team. The lawsuit claims that Orthofix's management team...
2025-01-06 5:54 PM EST
Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 3, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Prime Medicine, Inc. (NASDAQ: PRME) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term PRME stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call...
2025-01-03 1:22 PM EST
Kuehn Law Encourages Investors of Cytokinetics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 3, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Cytokinetics, Inc. (NASDAQ: CYTK) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term CYTK stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call...
2025-01-03 12:45 PM EST
Kuehn Law Encourages Investors of Starbucks Corp to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Starbucks Corp (NASDAQ: SBUX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Starbucks insiders caused the company to misrepresent or fail to disclose material information concerning Starbucks' fiscal year revenue for 2023 and expected guidance for the fiscal year 2024. On April...
2024-12-31 4:16 PM EST
Kuehn Law Encourages Investors of DexCom, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, DexCom insiders caused the company to misrepresent or fail to disclose material information concerning expected revenue for the fiscal year 2024. On July 25, 2024, Dexcom announced its financial results for...
2024-12-31 4:13 PM EST
Kuehn Law Encourages Investors of Mobileye Global Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Mobileye Global Inc. (NASDAQ: MBLY) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Mobileye Global insiders caused the company to misrepresent or fail to disclose that (1) to avoid the shortages experienced amid supply chain constraints in 2021 and 2022, the company's Tier 1...
2024-12-31 4:09 PM EST
Kuehn Law Encourages Investors of Gitlab Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Gitlab Inc. (NASDAQ: GTLB) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Gitlab insiders caused the company to misrepresent or fail to disclose material adverse facts concerning GitLab's ability to develop AI features that would generate code more efficiently and increase market...
2024-12-31 1:06 PM EST
Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Outset Medical, Inc. (NASDAQ: OM) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Outset insiders caused the company to misrepresent or fail to disclose that (1) the Tablo products were marketed for continuous renal replacement therapy, which is not one of the indications approved...
2024-12-31 12:54 PM EST
Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Sage Therapeutics, Inc. (NASDAQ: SAGE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Sage insiders caused the company to misrepresent or fail to disclose that (i) zuranolone was less effective in treating MDD than the company had led investors to believe; (ii) accordingly, the FDA...
2024-12-31 12:50 PM EST
Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 30, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Akero Therapeutics, Inc. (NASDAQ: AKRO) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term AKRO stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or...
2024-12-30 5:30 PM EST
Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 30, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Inc. (NASDAQ: CORT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term CORT stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or...
2024-12-30 5:26 PM EST
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 30, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Immunovant, Inc. (NASDAQ: IMVT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term IMVT stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call...
2024-12-30 5:23 PM EST
Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 28, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term SNDX stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law,...
2024-12-28 1:38 PM EST
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 28, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term PGNY stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833)...
2024-12-28 1:08 PM EST
Kuehn Law Encourages Investors of Krystal Biotech, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 28, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Krystal Biotech, Inc. (NASDAQ: KRYS) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term KRYS stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or...
2024-12-28 1:00 PM EST
Kuehn Law Encourages Investors of Riot Platforms, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 28, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Riot Platforms, Inc. (NASDAQ: RIOT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term RIOT stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call...
2024-12-28 12:58 PM EST
Kuehn Law Encourages Investors of Cara Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 20, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Cara Therapeutics, Inc. (NASDAQ: CARA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term CARA stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or...
2024-12-20 3:32 PM EST